Literature DB >> 7494254

Assembly and catalytic properties of retrovirus integrase-DNA complexes capable of efficiently performing concerted integration.

A C Vora1, D P Grandgenett.   

Abstract

The in vitro assembly process for forming nucleoprotein complexes containing linear retrovirus-like DNA and integrase (IN) was investigated. Solution conditions that allowed avian myeloblastosis virus IN to efficiently pair two separate linear DNA fragments (each 487 bp in length) containing 3' OH recessed long terminal repeat termini were established. Pairing of the viral termini by IN during preincubation on ice permitted these nucleoprotein complexes to catalyze the concerted insertion of the two termini into a circular DNA target (full-site reaction), mimicking the in vivo reaction. The three major solution determinants were high concentrations of NaCl (0.33 M), 1,4-dioxane, and polyethylene glycol. The aprotic solvent dioxane (15%) was significantly better (sixfold) than 15% dimethyl sulfoxide for forming complexes capable of full-site rather than half-site integration events. Half-site reactions by IN involved the insertion of a single donor terminus into circular pGEM. Although NaCl was essential for the efficient promotion of the concerted integration reaction, dioxane was necessary to prevent half-site reactions from occurring at high NaCl concentrations. Under optimal solution conditions, the concerted integration reaction was directly proportional to a sixfold range of IN. The complexes appeared not to turn over, and few half-site donor-donor molecules were produced. In the presence of 0.15 or 0.35 M NaCl, dioxane prevented efficient 3' OH trimming of a blunt-ended donor by IN, suggesting that the complexes formed by IN with blunt-ended donors were different from those formed with donors containing 3' OH recessed termini for strand transfer. The results suggest that IN alone was capable of protein-protein and protein-DNA interactions that efficiently promote the in vitro concerted integration reaction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7494254      PMCID: PMC189686     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  The Mu transpositional enhancer can function in trans: requirement of the enhancer for synapsis but not strand cleavage.

Authors:  M G Surette; G Chaconas
Journal:  Cell       Date:  1992-03-20       Impact factor: 41.582

2.  Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases.

Authors:  J Kulkosky; K S Jones; R A Katz; J P Mack; A M Skalka
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

3.  Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex.

Authors:  C M Farnet; W A Haseltine
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

4.  A mutation at one end of Moloney murine leukemia virus DNA blocks cleavage of both ends by the viral integrase in vivo.

Authors:  J E Murphy; S P Goff
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

5.  Relationship of avian retrovirus DNA synthesis to integration in vitro.

Authors:  Y M Lee; J M Coffin
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

6.  Correct integration of retroviral DNA in vitro.

Authors:  P O Brown; B Bowerman; H E Varmus; J M Bishop
Journal:  Cell       Date:  1987-05-08       Impact factor: 41.582

7.  Transposition of Mu DNA: joining of Mu to target DNA can be uncoupled from cleavage at the ends of Mu.

Authors:  R Craigie; K Mizuuchi
Journal:  Cell       Date:  1987-11-06       Impact factor: 41.582

8.  Integration of human immunodeficiency virus type 1 DNA in vitro.

Authors:  C M Farnet; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

9.  Identification of amino acid residues critical for endonuclease and integration activities of HIV-1 IN protein in vitro.

Authors:  M Drelich; R Wilhelm; J Mous
Journal:  Virology       Date:  1992-06       Impact factor: 3.616

10.  Development of an acid-soluble assay for measuring retrovirus integrase 3'-OH terminal nuclease activity.

Authors:  M L Fitzgerald; A C Vora; D P Grandgenett
Journal:  Anal Biochem       Date:  1991-07       Impact factor: 3.365

View more
  21 in total

1.  DNase protection analysis of retrovirus integrase at the viral DNA ends for full-site integration in vitro.

Authors:  A Vora; D P Grandgenett
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  Correct integration of model substrates by Ty1 integrase.

Authors:  S P Moore; D J Garfinkel
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Cofactors for human immunodeficiency virus type 1 cDNA integration in vitro.

Authors:  Kui Gao; Robert J Gorelick; Donald G Johnson; Frederic Bushman
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 4.  Integrase, LEDGF/p75 and HIV replication.

Authors:  E M Poeschla
Journal:  Cell Mol Life Sci       Date:  2008-05       Impact factor: 9.261

5.  Biochemical and biophysical analyses of concerted (U5/U3) integration.

Authors:  Duane P Grandgenett; Sibes Bera; Krishan K Pandey; Ajaykumar C Vora; Jacob Zahm; Sapna Sinha
Journal:  Methods       Date:  2008-11-29       Impact factor: 3.608

6.  A large nucleoprotein assembly at the ends of the viral DNA mediates retroviral DNA integration.

Authors:  S Q Wei; K Mizuuchi; R Craigie
Journal:  EMBO J       Date:  1997-12-15       Impact factor: 11.598

7.  High-resolution functional mapping of a cloned gene by genetic footprinting.

Authors:  I R Singh; R A Crowley; P O Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

8.  Assembly and catalysis of concerted two-end integration events by Moloney murine leukemia virus integrase.

Authors:  F Yang; M J Roth
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

9.  Detection and Removal of Nuclease Contamination During Purification of Recombinant Prototype Foamy Virus Integrase.

Authors:  Miguel A Lopez; Randi M Mackler; Matthew P Altman; Kristine E Yoder
Journal:  J Vis Exp       Date:  2017-12-08       Impact factor: 1.355

10.  Molecular and genetic determinants of rous sarcoma virus integrase for concerted DNA integration.

Authors:  Roger Chiu; Duane P Grandgenett
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.